Ultrasound‐based measurement of central adiposity: Key considerations and guidelines

Summary Central adiposity, which is visceral and subcutaneous adiposity in the abdominal region, is a known risk factor for developing chronic cardiometabolic diseases. Central adiposity can be measured relatively inexpensively using ultrasound. Ultrasound has been shown to be precise and reliable,...

Full description

Saved in:
Bibliographic Details
Published inObesity reviews Vol. 25; no. 5; pp. e13716 - n/a
Main Authors Zieff, Gabriel, Cornwall, Jon, Blue, Malia N., Smith‐Ryan, Abbie E., Stoner, Lee
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.05.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary Central adiposity, which is visceral and subcutaneous adiposity in the abdominal region, is a known risk factor for developing chronic cardiometabolic diseases. Central adiposity can be measured relatively inexpensively using ultrasound. Ultrasound has been shown to be precise and reliable, with measurement accuracy comparable to computed tomography and magnetic resonance. Despite the advantages conferred by ultrasound, widespread adoption has been hindered by lack of reliable standard operating procedures. To consolidate the literature and bring clarity to the use of ultrasound‐derived measures of central adiposity, this review outlines (i) the [patho]physiological importance of central adiposity to cardiometabolic disease risk; (ii) an overview of the history and main technical aspects of ultrasound methodology; (iii) key measurement considerations, including transducer selection, subject preparation, image acquisition, image analysis, and operator training; and (iv) guidelines for standardized ultrasound protocols for measuring central adiposity.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1467-7881
1467-789X
DOI:10.1111/obr.13716